Dosage regimen for an S1P receptor modulator or agonist

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Wallstroem, Erik

申请号：

AU2012324867

公开号：

AU2012324867B2

申请日:

2012.10.18

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

This invention relates to a method of treating multiple sclerosis in a mammalian patient, preferably a human, in need of such treatment, comprising administering to said human an S1P receptor modulator or agonist according to a dosing regimen that is determined with reference to the patient's blood lymphocyte count.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/